Markets:

Overview

News

Currencies

International

Treasuries

Renaissance Capital Greenwich Fund (NY:IPOS)

22.25 -0.50 (-2.18%)

Official Closing Price Updated: 4:10 PM EDT, Jun 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Renaissance Capital Greenwich Fund

IPO Rebound In 2025? Here's What's Fueling The Boom, How ETFs Can Help Investors Capitalize ↗

January 24, 2025

The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business environment. Consider ETFs for this trend.

Via Benzinga

Topics ETFs Initial Public Offering

Weight-Loss Drug Gold Rush Gets Larger As New Player Fractyl Health Files For $100M IPO ↗

December 15, 2023

Fractyl Health, developing procedural and gene therapies for type 2 diabetes and obesity, filed an S-1 filing with the SEC on Thursday to raise up to $100 million in an initial public offering.

Via Benzinga

Topics Regulatory Compliance

European Private Equity CVC Capital Partners Defies Market Pessimism, Weighs Amsterdam IPO Next Week ↗

October 19, 2023

CVC Capital Partners, one of Europe's leading private equity groups with €161 billion under management, is set to make an audacious move by announcing its intention to go public in Amsterdam.

Via Benzinga

Topics Initial Public Offering

Instacart and Arm's Stock Decline Sparks Concerns Over Tech Sector IPOs ↗

September 21, 2023

Investors in recently listed tech companies Arm Holdings Plc (NASDAQ:

Via Benzinga

Radiopharmaceuticals Startup RayzeBio Seeks Public Debut After Raising $400M From Investors ↗

August 25, 2023

RayzeBio Inc, a San Diego company focused on radiopharmaceutical therapies for cancer, filed on Thursday to raise up to $1

Via Benzinga

Healthcare Software Firm Waystar Goes IPO Way With Potential $8B Valuation ↗

August 22, 2023

Waystar Inc, a provider of financial management software for hospitals and medical practices, is reportedly making strides toward an initial public offering (IPO) that could value the company up to $8...

Via Benzinga

Topics Initial Public Offering

Second Time Charm: Sagimet Biosciences Seeks Public Debut With $75M IPO ↗

June 26, 2023

On Friday, Sagimet Biosciences, a clinical-stage biopharmaceutical company, filed with the SEC to raise up to $75 million in an initial public off

Via Benzinga

7 ETFs to Buy on Sale After Falling 30% in 2021 ↗

December 20, 2021

Some of the worst-performing funds of 2021 could be the best ETFs to buy for 2022. Here are seven that ought to rebound in the year ahead. 7 ETFs to Buy on Sale After Falling 30% or More in 2021

Via InvestorPlace

2021 Likely to be a Record Year for IPOs: ETFs to Win ↗

October 23, 2021

There have been 480 SPAC IPOs this year, with healthcare taking about 38% total volume, followed by technology (31% weight). Companies are also joining the IPO stream to go public in a stock market at...

Via Talk Markets

Topics Initial Public Offering

With IPOs Red Hot, What's Next for ETFs? ↗

October 07, 2021

Capital markets are very hot this year. Money raised by US IPOs in 2021, including SPACs, is already the highest on record for any full year, per WSJ.

Via Talk Markets

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.